Essential Role of Stat3 in PI3K-Induced Oncogenic Transformation
Total Page:16
File Type:pdf, Size:1020Kb
Essential role of Stat3 in PI3K-induced oncogenic transformation Jonathan R. Harta, Lujian Liaob, John R. Yates IIIb, and Peter K. Vogta,1 aDepartment of Molecular and Experimental Medicine and bDepartment of Chemical Physiology, The Scripps Research Institute, La Jolla, CA 92037 Contributed by Peter K. Vogt, June 28, 2011 (sent for review March 2, 2011) Cells transformed by the p110α-H1047R mutant of PI3K show in- generate a positive autocrine feedback leading to activation of creased tyrosine phosphorylation of Stat3. This activation of Stat3 Stat3 (16). is important for the transformation process, because a dominant- The PI3K signaling pathway is part of the core regulatory negative mutant of Stat3 interferes with PI3K-induced oncogene- networks in the cell and affects virtually all cellular activities, sis. GDC-0941, a specific inhibitor of PI3K reduces the level of Stat3 including growth, replication, movement, differentiation, and phosphorylation. The effect of PI3K on Stat3 appears to be medi- metabolism. PI3K signaling is elevated in most human cancers. ated by a member of the Tec kinase family. The Tec kinase inhib- This aberrant activity can result from differential regulation of itor LFM-A13 blocks Stat3 phosphorylation in H1047R-transformed PI3K itself or members of the pathway; it can also be caused by cells. The Janus kinase inhibitor AG490 and the Src kinase inhibitor gain-of-function mutations in the pathway or loss-of-function Src-1, as well as rapamycin, have no effect on Stat3 phosphoryla- mutations in the PI3K antagonist PTEN. The PI3K pathway tion in H1047R-transformed cells. The H1047R-transformed cells connects to numerous other signaling nodes including Ras, p53, also release a factor that induces Stat3 phosphorylation in normal Hif1α, and Lkb1. However, crosstalk between PI3K and Stat cells with possible effects on the cellular microenvironment. In signaling has not been reported. Here we describe a unique link some human tumor cell lines, the enhanced phosphorylation of between Stat3 and PI3K. In PI3K-transformed cells, Stat3 is Stat3 is inhibited by both PI3K and by Tec kinase inhibitors, sug- activated. This activation is essential for the process of trans- fi gesting that the link between PI3K and Stat3 is signi cant in formation. Inhibition of PI3K prevents Stat3 phosphorylation, human cancer. and dominant-negative Stat3 interferes with PI3K-induced on- cogenic transformation. MEDICAL SCIENCES oncogenic signaling | tumor stroma | tyrosine kinase Results tat3 is a member of a transcription factor family that was Stat3 Is Activated in C3H 10T1/2 Mouse Fibroblasts Transformed by Sdiscovered during the analysis of IFN-induced transcription the PI3K Mutant p110α-H1047R. We have used stable isotope la- (1–6). Stats are transcriptional regulators controlled by a path- beling with amino acids in cell culture (SILAC) in conjunction way that can be activated by growth factor as well as cytokine with tandem mass spectrometry to analyze the changes to the receptors (7). Stat3 is activated in response to the epidermal global proteome induced by the expression of the oncogenic growth factor and to IL-6 (2). Activation by IL-6 is primarily H1047R mutant of p110α in C3H 10T1/2 cells (26). The up- mediated by receptor-associated kinases of the Janus kinase (Jak) regulated PI3K signaling in the H1047R-transformed cells is family, which phosphorylate cytoplasmic Stats at tyrosine, effect- documented in Fig. 1A. Several of the proteins up-regulated by ing dimerization, translocation into the nucleus, sequence-specific p110α-H1047R are known targets of Stats (Table 1) (26–32). The DNA binding, and transcriptional activation (8). corresponding genes contain IFN-stimulated response elements The role of Stats, however, goes far beyond the IFN response. or IFN-γ activation sites (GAS). These binding sites interact with Stat3 is an important and often essential factor in oncogenic the IFN-stimulated gene factor 3 complex which contains both cellular transformation and in cancer. It is a required target of IFN response factor and Stat proteins. We therefore investigated the Src oncoprotein (9). Expression of dominant-negative Stat3 possible activation of Stat proteins by phosphorylation (Fig. 1B). blocks Src-induced cellular transformation. Stat3 is frequently The activation of Stat proteins by phosphorylation was evaluated and persistently activated in a wide variety of cancers (10). Mu- by Western blotting. The p110α-H1047R-transformed 10T1/2 rine cells in which Stat3 has been genetically inactivated are re- cells show enhanced phosphorylation of Stat3 and Stat6 and a sistant to oncogenic transformation (11, 12). Constitutively active decrease of phosphorylation in Stat1 (Fig. 1B). Because of the mutants of Stat3 are sufficient to convert normal cells into cancer prominent role of Stat3 in cancer (9–13), we decided to inves- cells (13). tigate its significance in PI3K-induced oncogenic transformation. The canonical kinases of Stat are members of the Jak family. There is no tyrosine kinase in the canonical PI3K signaling However, several other tyrosine kinases can phosphorylate and pathway. However, activated TOR (target of rapamycin) can activate Stats, including both receptor tyrosine kinases, such as phosphorylate S727 of Stat3 (33, 34) and this phosphorylation Egfr (14), Fgfr (15), Met (16), and Erbb2 (17), and nonreceptor enhances the activity of Stat3. However, in the two 10T1/2 cell tyrosine kinases, such as the Src and Fak kinase families. Such lines, S727 is constitutively phosphorylated, regardless of the ex- noncanonical Stat kinases are activated either through mutation pression of p110α-H1047R (Fig. 1B). It is therefore unlikely that – or through the aberrant expression of cytokines (18 20). In the enhanced expression of Stat targets in PI3K-transformed chronic myelogenous leukemia, the BCR-ABL fusion kinase also cells is mediated by TOR. In the context of the following ex- mediates Stat3 phosphorylation, and the leukemic cells are de- pendent upon this activity for sustained proliferation (21). Activation of Stat transcription factors induces a variety of Author contributions: J.R.H., J.R.Y., and P.K.V. designed research; J.R.H., L.L., J.R.Y., and proliferative and prosurvival proteins as they suppress immune P.K.V. performed research; J.R.H., L.L., and J.R.Y. contributed new reagents/analytic tools; responses (22). Stat proteins enhance the expression of the J.R.H., L.L., J.R.Y., and P.K.V. analyzed data; and J.R.H. and P.K.V. wrote the paper. antiapoptotic Bcl2 and Bcl-XL (13) and repress the expression of The authors declare no conflict of interest. proapoptotic proteins, such as p53 (23). Many growth factors are 1To whom correspondence should be addressed. E-mail: [email protected]. under Stat3 transcriptional control, including VEGF (24) and This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10. HGF (25). Constitutive expression of these growth factors can 1073/pnas.1110486108/-/DCSupplemental. www.pnas.org/cgi/doi/10.1073/pnas.1110486108 PNAS Early Edition | 1of6 Downloaded by guest on October 2, 2021 phosphorylation of Y705 on Stat3 indicating that PI3K activity is essential for this phosphorylation event. Cells Expressing p110α-H1047R Release a Stat3-Activating Factor. The reduction of Stat3 phosphorylation by a PI3K inhibitor does not rule out an IFN response to the retroviral vector. To explore a potential role of IFN further, we transfected 10T1/2 cells with the TLR3/RIG-I agonist poly-I:C to trigger an authentic IFN response. Cell-free conditioned medium from these cells and from nontransfected H1047R-expressing cells was then used to stimulate 10T1/2 cells. The cells were lysed 2 h after exposure to the conditioned medium and analyzed by Western blot. IFN produced in response to poly-I:C transfection triggered a large increase in the expression of Isg15, but did not affect phos- phorylation of Stat3 (Fig. 1D). In contrast, medium conditioned by H1047R-transformed cells strongly stimulated the phosphor- ylation of Stat3, but had no effect on the production of Isg15. These data suggest that H1047R-transformed cells do not re- lease detectable quantities of IFN, but release a factor that can stimulate the phosphorylation of Stat3. The nature of this factor Fig. 1. (A) PI3K signaling in cells transformed by the H1047R mutant of is not known but is currently under investigation. p110α. The Western blot shows expression of p110α and phosphorylation of Akt and of S6 in the presence and in the absence of serum. H1047R-trans- Dominant-Negative Mutant of Stat3 Interferes with PI3K-Induced formed cells show constitutive activation of PI3K signaling in the absence of Oncogenic Transformation. To determine the functional signifi- serum. (B) Phosphorylation of Stat proteins. 10T1/2 and 10T1/2-H1047R cells cance of Stat3 activation in H1047R-induced transformation, we were lysed and probed for the indicated tyrosine phosphorylations of Stat examined a dominant negative, DNA binding-defective form of proteins. Transformation by p110α-H1047R induces an increase in Stat3 and Stat3 for its ability to affect the oncogenic potency of p110α- Stat6 phosphorylation and a decrease in Stat1 phosphorylation. S727 of fi Stat3, a known TOR phosphorylation site, is unaffected. (C) The PI3K in- H1047R. Chicken embryonic broblasts were transfected with hibitor GDC-0941 blocks tyrosine phosphorylation of Stat3. The 10T1/2- RCAS(B)-Stat3DB (9) or RCAS(B) as a vector control. After H1047R cells were treated with 20 μM GDC-0941 for 0, 1, 6, 24, or 48 h as 6 d to allow full expression of the dominant-negative Stat3, the indicated and then analyzed by Western blot. (D) IFN stimulation. 10T1/2 cultures were superinfected with serial dilutions of RCAS(A) ex- cells were exposed to conditioned medium from either 10T1/2-H1047R or pressing the oncogenic H1047R mutant of p110α or with ASV17 from normal 10T1/2 cells transfected with poly-I:C.